Les Sulewski
Stock Analyst at Truist Securities
(0.89)
# 3,927
Out of 5,169 analysts
19
Total ratings
41.18%
Success rate
-15.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Les Sulewski
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VNDA Vanda Pharmaceuticals | Initiates: Buy | $18 | $8.56 | +110.28% | 1 | Mar 5, 2026 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $15 → $17 | $12.39 | +37.21% | 4 | Mar 2, 2026 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Buy | $38 → $42 | $29.61 | +41.84% | 3 | Feb 18, 2026 | |
| BHC Bausch Health Companies | Maintains: Hold | $7 → $8 | $5.09 | +57.17% | 1 | Jan 7, 2026 | |
| PCRX Pacira BioSciences | Maintains: Buy | $30 → $28 | $22.02 | +27.16% | 7 | Nov 7, 2025 | |
| COLL Collegium Pharmaceutical | Maintains: Buy | $45 → $48 | $34.80 | +37.93% | 3 | Nov 7, 2025 |
Vanda Pharmaceuticals
Mar 5, 2026
Initiates: Buy
Price Target: $18
Current: $8.56
Upside: +110.28%
Amneal Pharmaceuticals
Mar 2, 2026
Maintains: Buy
Price Target: $15 → $17
Current: $12.39
Upside: +37.21%
Teva Pharmaceutical Industries
Feb 18, 2026
Maintains: Buy
Price Target: $38 → $42
Current: $29.61
Upside: +41.84%
Bausch Health Companies
Jan 7, 2026
Maintains: Hold
Price Target: $7 → $8
Current: $5.09
Upside: +57.17%
Pacira BioSciences
Nov 7, 2025
Maintains: Buy
Price Target: $30 → $28
Current: $22.02
Upside: +27.16%
Collegium Pharmaceutical
Nov 7, 2025
Maintains: Buy
Price Target: $45 → $48
Current: $34.80
Upside: +37.93%